Pier Vincenzo Piazza
Oprichter bij AELIS FARMA
Oorsprong van het eerstegraads netwerk van Pier Vincenzo Piazza
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
12
| Public Company | Biotechnology | 12 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Pier Vincenzo Piazza via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| University of Copenhagen | College/University | Doctorate Degree Graduate Degree | |
TopoTarget UK Ltd.
 TopoTarget UK Ltd. Drugstore ChainsRetail Trade TopoTarget UK Ltd. engages in the discovery and development of drugs and therapies to treat cancer. It develops anti-cancer drugs for molecular mechanisms associated with the cell cycle, chromatin control and DNA damage. The company was founded in 2002 and is headquartered in Oxford, the United Kingdom. | Drugstore Chains | Director/Board Member | |
Emergence Therapeutics AG
 Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Pharmaceuticals: Major | Chairman | |
| Talix Therapeutics NV | Chairman | ||
BliNK Biomedical SAS
 BliNK Biomedical SAS BiotechnologyHealth Technology BliNK Biomedical SAS is a French company that specializes in cutting-edge technology for identifying rare antibody-secreting cells from humans and other species. The company is based in Marseille, France. The company's technology is based on validated platforms, isaac and vivascreen, which provide a highly efficient and deep mining process. The CEO of the company is Jack Elands. | Biotechnology | Chief Executive Officer | |
| Pharma-Lizenz-Club Deutschland | Chairman | ||
BioNet Pharma GmbH
 BioNet Pharma GmbH Miscellaneous Commercial ServicesCommercial Services BioNet Pharma GmbH engages in development of medical devices, pharmaceutical drugs and regenerative medical products. Its pipeline covers pre-clinical and clinical development programs in osteoarthritis, inflammatory joint disease, cartilage injury, and severe gingival inflammation. The company is headquartered in Martinsried, Germany. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Staatz Business Development & Strategy | Founder | ||
| INNATE PHARMA | Pharmaceuticals: Major | Chairman | |
Kepler Cheuvreux SA
 Kepler Cheuvreux SA Investment Banks/BrokersFinance Kepler Cheuvreux SA is an independent broker/dealer headquartered in Paris, France. The firm was founded by Laurent Quirin in 1997. Kepler Cheuvreux provides execution services to institutional investors. It supports equities, fixed income, derivatives, ETFS, and convertible bonds across Europe, America and Asia. | Investment Banks/Brokers | Analyst-Equity | |
HERMAL Kurt Herrmann GmbH & Co. oHG
 HERMAL Kurt Herrmann GmbH & Co. oHG Pharmaceuticals: MajorHealth Technology HERMAL Kurt Herrmann GmbH & Co. oHG provides skin care products. The company develops products for the treatment of skin related diseases. It is a dermatological company with marketing and sales departments throughout Europe and a production unit based in Germany. HERMAL Kurt Herrmann was founded in 1946 and is headquartered in Reinbek, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Eberhard Karls Universität Tübingen | College/University | Doctorate Degree | |
| Philipps University of Marburg | College/University | Undergraduate Degree | |
U3 Pharma AG
 U3 Pharma AG Miscellaneous Commercial ServicesCommercial Services U3 Pharma AG researches and develops novel targeted therapeutics aimed at treating human disease. It develops products for hyperproliferative diseases such as cancer and commercializes human monoclonal antibody therapies directed against validated proprietary drug targets selected from its portfolio. In addition, it has created a second generation functional genomics platform, TASC, which mimics the progression of a tumor cell as it progresses towards its fully malignant cancerous state. Founded in 2001, the company is headquartered in Martinsried, Germany. | Miscellaneous Commercial Services | Chief Executive Officer | |
Quadrille Capital SAS
 Quadrille Capital SAS Investment ManagersFinance Quadrille Capital SAS (Quadrille Capital) is an independent private equity firm founded in 2007. The firm is headquartered in Paris, France with an additional office in United States. | Investment Managers | Private Equity Investor | |
| Universite Paris Cite | College/University | Graduate Degree | |
INSERM Transfert Initiative SAS
 INSERM Transfert Initiative SAS Investment ManagersFinance INSERM Transfert Initiative SAS is a venture capital fund that invests in companies located in France. It targets startups from the life sciences and biotechnology sectors, developing new medical practices with a strong intellectual property. It invests between €1 million and €3 million per company during mostly at pre-seed, seed and early-stages. | Investment Managers | Chairman | |
CIC Market Solutions SA
 CIC Market Solutions SA Investment Banks/BrokersFinance CIC Market Solutions SA is the broker-dealer subsidiary of Crédit Industriel et Commercial SA, ultimately owned by Groupe Crédit Mutuel in France. Headquartered in Paris, the firm was founded in 1991 and handles commercial market activities for corporate and professional investor clients of Crédit Mutuel Alliance Fédérale group. CIC Market Solutions also provides primary equity and bond market services and execution and sale on the capital markets. | Investment Banks/Brokers | Analyst-Equity | |
| EM Lyon Business School | College/University | Undergraduate Degree | |
| BERGENBIO ASA | Pharmaceuticals: Major | Director/Board Member | |
| Universite Toulouse 1 Capitole | College/University | Undergraduate Degree | |
| Toulouse Business School - TBS EESC | College/University | Masters Business Admin | |
| Université Libre de Bruxelles | College/University | Corporate Officer/Principal | |
Health Economics & Outcomes Research Ltd.
 Health Economics & Outcomes Research Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2011, Health Economics & Outcomes Research Ltd. is a British management consulting company that provides consulting services. The company is based in Cardiff, UK and is part of HEOR Holdings Ltd. | Miscellaneous Commercial Services | Director/Board Member | |
Lundbeck SAS
 Lundbeck SAS Pharmaceuticals: MajorHealth Technology Lundbeck SAS is a pharmaceutical laboratory, which focuses on neurology and psychiatry. The company was founded in 1992 and is headquartered in Paris La Defense, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Université Paris-Saclay | College/University | Doctorate Degree | |
| Université de Limoges | College/University | Masters Business Admin | |
| Georgetown University Law Center | College/University | Corporate Officer/Principal | |
| SANOFI | Biotechnology | General Counsel | |
| EUROAPI | Biotechnology | Director/Board Member | |
Global Antibiotic Research & Development Partnership
 Global Antibiotic Research & Development Partnership BiotechnologyHealth Technology Global Antibiotic Research & Development Partnership is a Swiss company that is working to combat antibiotic resistance. The non-profit company is based in Geneva, Switzerland. Antibiotic resistance occurs when bacteria no longer respond to treatment, and millions of people suffer from this every year. The company is developing a new initiative called SECURE, which aims to provide access to essential antibiotics and prepare for and respond to pandemics. | Biotechnology | Director/Board Member | |
Sanofi-Aventis Deutschland GmbH
 Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany. | Pharmaceuticals: Major | Director/Board Member | |
| CNH INDUSTRIAL N.V. | Trucks/Construction/Farm Machinery | Director/Board Member | |
| VEON LTD. | Wireless Telecommunications | Director/Board Member | |
Hoechst GmbH
 Hoechst GmbH Pharmaceuticals: MajorHealth Technology Part of Sanofi, Hoechst GmbH is a German company that manufactures and sells drugs. The company is based in Frankfurt, Germany. The CEO of the company is Fabrizio Guidi. | Pharmaceuticals: Major | Director/Board Member | |
| Georgetown University | College/University | Graduate Degree | |
Sofimac Régions SAS
 Sofimac Régions SAS Investment ManagersFinance Sofimac Régions SAS is a Private Equity/Venture Capital firm, a subsidiary of Sofimac Investment Managers SAS founded in 1978. Sofimac Régions is headquartered in Clermont-Ferrand. | Investment Managers | Private Equity Investor | |
Axilum Robotics SAS
 Axilum Robotics SAS Miscellaneous Commercial ServicesCommercial Services Axilum Robotics SAS develops and commercializes robotic solutions designed to assist medical professionals in the implementation of technical gestures. Its first project is a robot to assist psychiatrists and neurologists for Transcranial Magnetic Stimulation (TMS). The firm's project TMS is a painless, non invasive medical technique that applies high intensity magnetic impulses to cortex areas by placing a coil on the surface of the head. The company was founded by Bernard Bayle, Michel Berg, Michel de Mathelin, Romuald Ginhoux, Benjamin Maurin and Pierre Renaud in April 2011 and is headquartered in Strasbourg, France. | Miscellaneous Commercial Services | Director/Board Member | |
| ALK-ABELLÓ A/S | Biotechnology | Director/Board Member | |
Bavarian Nordic GmbH
 Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | Biotechnology | Director/Board Member | |
| HANSA BIOPHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
| GENMAB A/S | Pharmaceuticals: Major | Director/Board Member | |
| Lundbeck Cognitive Therapeutics A/S | Director/Board Member | ||
| Fonden Lundbeck International Neuroscience Foundation | Investment Trusts/Mutual Funds | Chairman | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Copenhagen Business School | College/University | Undergraduate Degree |
Statistieken
Internationaal
| Frankrijk | 18 |
| Duitsland | 12 |
| Denemarken | 7 |
| Verenigd Koninkrijk | 5 |
| Verenigde Staten | 5 |
Sectoraal
| Health Technology | 19 |
| Consumer Services | 14 |
| Commercial Services | 6 |
| Finance | 6 |
| Retail Trade | 2 |
Operationeel
| Director/Board Member | 38 |
| Corporate Officer/Principal | 18 |
| Independent Dir/Board Member | 12 |
| Chairman | 11 |
| Chief Executive Officer | 8 |
Sterkste connecties
- Beurs
- Insiders
- Pier Vincenzo Piazza
- Bedrijfsconnecties
